Key result
A de novo missense mutation in the FLNC gene (c.6451G>A, p.G2151S) was identified as the likely genetic cause of restrictive cardiomyopathy in a 20-year-old male proband.
Why the study?
Restrictive cardiomyopathy is a heterogeneous disease with genetic causes, and whole-exome sequencing was used to identify the genetic cause in an affected family to clarify diagnosis and treatment.
Case Report (n=3)
Identifies a de-novo missense mutation in the FLNC gene associated with restrictive cardiomyopathy, highlighting genetic overlap among cardiomyopathies.
WES identifies candidate variant in one RCM family; leaves open whether routine testing improves diagnosis or management.
Objective: Restrictive cardiomyopathy (RCM) is a heterogenous cardiomyopathy with various causes, and genetic variants take an important part of the pathogenesis. Whole-exome sequencing (WES) is effective to discover genes that cause genetic diseases. By using WES, we attempted to identify the genetic cause of an RCM family and clarify the clinical diagnosis of the patient and then provide a personalized treatment plan. Materials and Methods: Blood samples were obtained from the proband and his healthy parents. WES and Sanger sequencing were performed to identify the possible pathogenic gene. Co-segregation analysis was conducted for candidate variants, and the allele frequency was checked in databases including Ensembl, Exome Aggregation Consortium (ExAC) and Human Gene Mutation Database (HGMD). Furthermore, the potential effect of variant was predicted using various-free software such as SIFT, Polyphen-2 and Mutation Taster and the conservation was tested using multiple sequence alignments by ClustalX. Results: The proband was a 20 years old boy with severe heart failure symptoms including dyspnea, massive ascites, edema of both lower limbs and chest congestion. Echocardiography showed significant biatrial enlargement, normal left ventricular wall thickness and preserved systolic function of both ventricles. A missense mutation in FLNC (c.6451G>A, p.G2151S), encoded filamin-C was detected in proband by WES and Sanger sequencing, while it was not be found in his parents, we supposed that the FLNC mutation (c.6451G>A, p.G2151S) may be a de-novo mutation. Through multiple functional predictions, we found that it is a deleterious mutation and the mutation in filamin-C could alter its structure and normal function, contributing to RCM. Conclusion: Here, an FLNC missense mutation (c.6451G>A, p.G2151S) known to be pathogenic in hypertrophic cardiomyopathy, was found to be associated with RCM, indicating the genetic overlap among cardiomyopathies. This study provides insights into Phenotype-Genotype Correlations of RCM in patients with FLNC mutations.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) conducted a case report in Restrictive cardiomyopathy (n=3). FLNC missense mutation (c.6451G>A, p.G2151S) vs. Healthy parents without the mutation was evaluated on Identification of the genetic cause of restrictive cardiomyopathy. A de novo missense mutation in the FLNC gene (c.6451G>A, p.G2151S) was identified as the likely genetic cause of restrictive cardiomyopathy in a 20-year-old male proband.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: